Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
Sponsored by Stanford University
About this trial
Last updated 4 years ago
Study ID
42159
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
5 to 19 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals,
causes progressive aortic root dilation that can result in aortic dissection and sudden
death. Clinical care focuses on monitoring the aortic root by serial echocardiography
(echo) to guide medical treatment and elective aortic root surgery in a specialized
clinic every 6-12 months. This monitoring protocol, coupled with surgical intervention,
has doubled the median life expectancy which was previously only 32 years. However, this
surveillance carries significant health care costs at >$50 million dollars/year on echos
alone (at $3-4K each) in children and adolescents in the US, as well as substantial
burden on families residing far from specialized centers. A clinic visit delivered to MFS
patients via live-video conferencing at home (tele-visit) could shift this paradigm, if a
home echo could be obtained.
Here, the investigator will train parents of Pediatric Marfan patients to take echo
images using a hand held device, height, weight, blood pressure, medical history, and
listen to the heart of their child. Then, the investigators will ask them to take the
equipment home and collect the same data at home during a tele-clinic visit, with further
instruction by the study team through secure live-video conferencing.
What are the participation requirements?
Inclusion Criteria
- 5-19 years of age (patient)
- seen in at least 2 prior clinic visits
- Marfan syndrome by revised Ghent criteria
- presence of parent at home
Exclusion Criteria
- prior aortic surgery
- known cardiomyopathy
- known arrhythmia
- aortic root > 4.5 cm in prior clinic visit
- pregnancy